StockHound - Comments

StockHound

Attorney at McCormick & Laughton
Lawyer by trade, new to the world of finance and am interested in learning more.

Latest Comments
Trading Levels For The "Magnificent 7" + Futures
1 month ago

Cool, I'll follow you so I get a notification here once they are published and ready to view.

By the way, why are your videos formatted so oddly - very wide, but not tall at all.  Like a midget rectangle rather than a typical video?

Trading Levels For The "Magnificent 7" + Futures
1 month ago

Are these just self promotional commericials?  Or can I actually see some real content here?

Will Gold Manage To Break Above Its Mid-2022 Top?
1 year ago

Not sure I buy that gold will go that high.

In this article: GLD
A "Better Choice" For Pet Health
1 year ago

e suite plus co really like actually.  Has looked lost in public Mkts since ipo though.  Chairman flailing away with authorized buybacks, axe’d the ceo after a year, no investor interest,  now down 85% since ipo nearing the black.

In this article: BTTR
A "Better Choice" For Pet Health
1 year ago

Not really a fan of this stock or the CEO.

In this article: BTTR
180 Life Sciences: Why Investors Should Take Notice
1 year ago

This little darling is certainly under the radar. The CEO makes a good impression and very good case for this stock. At the current price, it's hard to not want to plunge in and see how high it goes. $ATNF

In this article: ATNF
Arqlite: The ESG Startup That Is Revolutionizing Construction Through Recycling
1 year ago

Sebastian Sajoux, great idea. Is this crowdfunding campaign still going on? 

Bitcoin Bounces Back After Falling To New 2022 Lows
1 year ago

Dead cat bounce. $12k
gif

In this article: BITCOMP
The Weekly Chart For Walgreen (WBA) Confirms The Bearish Picture
2 years ago

We are headed to the moon! That's pretty clear in this chart:

charts.stocktwits.com/.../original_360505971.png

In this article: WBA
Biotech Losers In 2021 That Could Bounce Big In The Second Half
2 years ago

$ATHA dropped price on allegations that ceo cheated on a research paper back 10 years ago. Interim ceo said leen kawas research from then had nothing to do with the current drug they are making. All the value here on atha is still in tact.

In this article: CCXI, IMRA, IMVT, ATHA, SGTX
1 to 10 of 34 comments

Following (0)

Followers (0)

Stocks I follow

General Stats

Article Comments

Received: 0
Created: 0